Type 1 diabetes has shifted from a condition once associated with early mortality to a chronic disease owing to the development of intensive insulin therapy, continuous glucose monitoring, and hybrid ...

One year after receiving CRISPR gene editing therapy at CHOP, a Delaware County baby is thriving, and doctors want to expand ...

February 25, 2026 marks one year since KJ, an infant born with severe carbamoyl phosphate synthetase 1 (CPS1) deficiency, became the world's first person to receive a personalized CRISPR-based gene ...

Researchers at UChicago have developed a nanoparticle system that can effectively deliver mRNA to insulin-producing cells, protecting them from the body’s autoimmune response ...

Scientists have identified how specific genetic changes function in cells to influence disease risk and other human health traits. By probing regions of DNA previously linked to disease, the work has ...

A new light-based sensor detects cancer markers at near-zero concentrations.

The company has shed its former “GenEdit” name and strategy in favor of a plan to develop its own medicines, starting with a ...

Sarah Marriott, who lives with Type 1 diabetes, argues that research must ensure equal access to new technologies.

Regenerative Medicine Market OverviewThe regenerative medicine market is projected to grow at a robust CAGR of 17% during the forecast period, driven by rising chronic disease incidence, increasing ...

In the book "What We Inherit," experts unpack long-standing myths about genes and how those myths could shape public opinion around emerging embryo-selection technologies.

One of the most promising is its cardiovascular disease therapy candidate CTX310, a single-treatment gene therapy that has ...

BACKGROUND: The entrance of naive T cells into lymph nodes (LNs) is a crucial step for induction of heart transplant acceptance under costimulatory blockade. Specialized blood vessels within the LN ...